| 1 |
33788669 | Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm? | 2021 Nov 17 |
2 |
| 2 |
31859592 | Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1. | 2020 Feb 14 |
3 |
| 3 |
32271680 | Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1". | 2020 Apr 10 |
1 |
| 4 |
32271683 | Letter by Borst Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa Driven Platelet Activation via Protease Activated Receptor-1". | 2020 Apr 10 |
1 |
| 5 |
32379576 | Letter by Violi et al Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1". | 2020 May 8 |
1 |
| 6 |
32379578 | Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1". | 2020 May 8 |
1 |
| 7 |
28035779 | Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2. | 2017 Sep |
2 |